Drug Testing Locations - Buckingham, CO

Drug Testing in Buckingham, CO

Buckingham, Colorado Statistics

In 2022, Buckingham, CO, located in Weld County, reported a 15% increase in opioid-related overdoses.

Methamphetamine seizures in Buckingham, CO, rose by 25% in 2021, according to the Weld County Sheriff's Office.

The Weld County Public Health Department highlighted that 30% of Buckingham high school students reported using marijuana in the past year.

In 2020, the rate of drug-related arrests in Buckingham, CO, was 420 per 100,000 population, as per Weld County records.

The Weld County Coroner's office recorded 12 drug overdose deaths in Buckingham, CO, in 2022.

A 2021 survey found that 18% of adults in Buckingham, CO, admitted to using illicit drugs in the past year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Buckingham, CO & Drug Testing Policies

Employers in Buckingham, CO, are adopting stringent drug testing policies to ensure a safe workplace environment. Companies frequently conduct pre-employment drug screenings and random tests to detect any illicit drug use among employees. This is in alignment with guidelines from the U.S. Department of Labor.

Many local businesses have integrated Employee Assistance Programs (EAPs) to offer confidential support for employees struggling with substance abuse. By providing these resources, employers aim to maintain productivity and employee well-being while adhering to regulations set forth by the Colorado Department of Labor and Employment.

Government Efforts with Drug Problems in Buckingham, CO

The government of Buckingham, CO, in collaboration with Weld County, has implemented various strategies to combat drug abuse. These include community outreach programs and educational initiatives to raise awareness about the dangers of drug use. More information can be accessed from the Weld County Public Health Department.

At the state level, the Colorado Department of Human Services has been actively involved in providing resources and support for drug prevention programs in Buckingham. Efforts include funding for rehabilitation centers and support groups, aimed at reducing drug dependence in the community. The department's resources can be found on their website.

Local Drug Busts & News in Buckingham, CO

Recent drug busts in Buckingham, CO, underscore the ongoing battle against narcotics trafficking. In mid-2023, a joint operation by the Weld County Sheriff's Office and the local Police Department led to the arrest of several individuals involved in a methamphetamine distribution ring.

Earlier in 2023, a significant seizure of opioids in Buckingham marked one of the largest in the county's recent history. The operation involved collaboration with federal agencies, highlighting the importance of multi-level cooperation in combating drug-related crimes.

Community events such as 'Take Back Day,' organized by the DEA and local law enforcement, provide residents with the opportunity to safely dispose of unused medications, reducing the risk of drug misuse and raising awareness about the dangers of substance abuse.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Buckingham, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Colorado Crisis Services

Denver Public Health

Colorado Department of Human Services

SAMHSA National Helpline

Alcoholics Anonymous Meetings CO

Narcotics Anonymous Meetings

Colorado Health Partnerships

Weld County Addiction Services

Drug Testing Near Buckingham, CO

Wiggins, CO

Fort Morgan, CO

Willard, CO

Masters, CO

Log Lane Village, CO

Morgan Heights, CO

Cornish, CO

Grover, CO

Orchard, CO

Goodrich, CO

Weldona, CO

Briggsdale, CO

Stoneham, CO

New Raymer, CO

Raymer, CO

Frequently Asked Questions

Customer Reviews